The Society for Immunotherapy of Cancer (SITC) hosted Session 303 during the 38th Annual Meeting & Pre-Conference Programs on Sunday, November 5, 2023. Available here are the presentation slides and video from “Session 303: Hot Topic Symposium: Advances in Gene Editing, Synthetic Biology and Designing Innovative Clinical Interventions” as permitted by presenters.
Marcela Maus, MD, PhD – Massachusetts General Hospital
Kole Roybal, PhD – University of California, San Francisco
The session will highlight current challenges and future solutions to develop safe and efficacious engineered immune cell therapies. Speakers will cover current clinical experience and challenges that limit efficacy, use of machine learning and AI to improve cell therapies, and strategies to engineer cells with advanced features to impact treatment of refractory cancers.
To view the entire program schedule (including presenter permission to post) please click here.
SITC 2023 Annual Meeting: Sunday, November 501:35:40